Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands

Head & Neck
Adriana J TimmermansMichiel W M van den Brekel

Abstract

The purpose of this study was to determine time trends for primary treatment modalities in advanced laryngeal cancer, overall survival (OS), and laryngectomy-free interval (LFI) over the last 2 decades in The Netherlands. We conducted an analysis of T3 to T4 laryngeal cancer data from 2 combined national (population-based and pathology-based) cancer registries. A total of 2072 T3 cases (14.7%) and 1722 T4 cases (12.2%) were identified. Total laryngectomy as primary treatment modality decreased, whereas radiotherapy (RT) increased. For T3 disease, 5-year OS after primary total laryngectomy (+/- adjuvant RT), RT, and chemoradiotherapy (CRT) was 49%, 47%, and 45%, respectively. For T4 disease, this was 48%, 34%, and 42% (overall p < .0001), respectively. Five-year LFI for T3 disease was 81% (RT) and 77% (CRT), and for T4 disease it was 81% and 87%, respectively. From 1991 to 2010 total laryngectomy as primary treatment modality for advanced laryngeal cancer decreased and RT increased. T3 disease showed similar survival rates for all primary treatment modalities. For T4 disease, total laryngectomy (+ adjuvant RT) showed the best survival. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1247-E1255, 2016.

References

Dec 1, 1992·American Journal of Surgery·J J ManniG J Hordijk
Jun 13, 1991·The New England Journal of Medicine·UNKNOWN Department of Veterans Affairs Laryngeal Cancer Study GroupWilliam G Henderson
Dec 1, 1993·Clinical Otolaryngology and Allied Sciences·R E Tjho-HeslingaG J Hordijk
Jul 27, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Johannes H A M KaandersUNKNOWN Dutch Cooperative Head and Neck Oncology Group
Jan 15, 2003·Archives of Otolaryngology--head & Neck Surgery·Randal S WeberJohn Ensley
Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Dec 21, 2004·International Journal of Cancer. Journal International Du Cancer·André Lopes CarvalhoLuiz Paulo Kowalski
Mar 15, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Michel van AgthovenPaul P Knegt
Sep 2, 2006·The Laryngoscope·Henry T HoffmanRobert A Robinson
Sep 5, 2006·Lancet·Jean BourhisUNKNOWN Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group
Dec 19, 2007·Archives of Otolaryngology--head & Neck Surgery·Amy Y Chen, Michael Halpern
Jun 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitchell MachtayK Kian Ang
Jan 28, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Milena SantUNKNOWN EUROCARE Working Group
May 2, 2009·Head & Neck·Ian GanlyJatin P Shah
May 16, 2009·The Laryngoscope·Christine G GourinEdward S Porubsky
Sep 15, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monique C de JongAdrian C Begg
Dec 22, 2010·Acta Oto-laryngologica. Supplementum·Shinpei KadaJuichi Ito
Jul 26, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ada G T M EgelmeerPhilippe Lambin
Jun 20, 2012·Archives of Otolaryngology--head & Neck Surgery·Eleonoor A R TheunissenMichiel W M van den Brekel
Nov 28, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arlene A ForastiereJay S Cooper
Jul 23, 2013·International Journal of Cancer. Journal International Du Cancer·Boukje A C van DijkEsther de Vries

❮ Previous
Next ❯

Citations

May 20, 2016·The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS·Patrick J SchulerMarc O Scheithauer
Jun 19, 2017·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Jacinto García LorenzoXavier León Vintró
Dec 13, 2016·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Gorkem EskiizmirHulya Ellidokuz
Jan 22, 2019·The Laryngoscope·Japke F PetersenMichiel W M van den Brekel
Feb 14, 2019·The Annals of Otology, Rhinology, and Laryngology·Omar H AhmedDavid Myssiorek
Aug 11, 2020·The Laryngoscope·Ann-Jean C C BeckValesca P Retèl
Apr 5, 2017·The Journal of the Acoustical Society of America·James M GilbertEd Holdsworth
Sep 28, 2017·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·G B HalmosB A C van Dijk
Apr 6, 2019·Indian Journal of Surgical Oncology·Narayana SubramaniamSubramania Iyer
May 6, 2020·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Barbora RepovaJan Betka
Jan 29, 2019·Acta Oto-laryngologica·Rebecca Tosca KarstenMichiel Wilhelmus Maria van den Brekel
Mar 3, 2021·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Martine F van der KampGyorgy B Halmos
Apr 18, 2021·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Aihemaiti WushouerXinliang Pan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.